Original Research
Published on 04 Sep 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
in Translational Pharmacology
![Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)](https://www.frontiersin.org/files/myhome article library/1457363/1457363_Thumb_400.jpg)
- 264 views
Original Research
Published on 04 Sep 2024
in Translational Pharmacology
Original Research
Published on 04 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 04 Sep 2024
in Biogeography and Macroecology
Editorial
Published on 04 Sep 2024
in General Cardiovascular Medicine
Original Research
Published on 04 Sep 2024
in Ethnopharmacology
Original Research
Published on 04 Sep 2024
in Microbe and Virus Interactions with Plants
Original Research
Published on 04 Sep 2024
in Neuropharmacology
Original Research
Published on 04 Sep 2024
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 04 Sep 2024
in Exercise Physiology
Original Research
Published on 04 Sep 2024
in Animal Breeding and Genetics
Original Research
Published on 04 Sep 2024
in Gastroenterology
Original Research
Published on 04 Sep 2024
in Cognition
Methods
Published on 04 Sep 2024
in Clinical Diabetes
Original Research
Published on 04 Sep 2024
in Healthcare Professions Education
Original Research
Published on 04 Sep 2024
in Cancer Immunity and Immunotherapy
Brief Research Report
Published on 04 Sep 2024
in Peace and Democracy